Other

Vertex Pharmaceuticals·Balance Sheet Statement·31 metrics

Breakdown

Loading...

Metrics

Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax

Business Combination, Contingent Consideration, Liability

Fair Value

Cash Equivalents And Debt Securities, Available for Sale

Cash Equivalents, Debt and Equity Securities, Cost

Total cash equivalents and marketable securities, Fair Value

Total cash equivalents and marketable securities, Gross Unrealized Gains

Cash Equivalents, Debt and Equity Securities, Unrealized Loss

Common stock, par value (in dollars per share)

Common stock, shares authorized (in shares)

Common stock, shares issued (in shares)

Common Stock, Shares, Outstanding

Contingent liabilities

Contract with Customer, Liability

Debt Securities, Available-for-Sale, Allowance for Credit Loss

Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss

Debt Securities, Available-for-Sale, Unrealized Loss Position

Debt and Equity Securities, Cost

Fair Value

Gross  Unrealized  Gains

Debt and Equity Securities, Unrealized Loss

Cost

Finite-Lived Intangible Assets, Accumulated Amortization

Indemnification claims

Indefinite- lived intangible impairment

Loss Contingency Accrual

Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Shares Authorized

Preferred Stock, Shares Issued

Share Repurchase Program, Remaining Authorized, Amount

Amount that if recognized, would affect the effective tax rate or regulatory liability